Manuel Kadre

This profile gathers the share dealings of Manuel Kadre across 2 companies, led by NeueHealth, Inc. and Pediatrix Medical Group, Inc. The record holds 14 filings, for trades running from 12 May 2021 to 2 October 2025.

Purchases make up the whole of the open-market record (9 purchases, €2.0M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 3 option exercises.

The median purchase comes to €189k. On 5 out of 9 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

On 6 October 2025 came the latest disclosure, a transaction in NeueHealth, Inc. The last insider purchase was made public on 16 December 2022, 1,402 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.